Trial Details

TERMINATED
Basic Information
Clinical ID c2880
Identifier NCT02847052
Trial Title Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease
Interventions OTHER: Non interventional study
Participant Information
Sponsor Nantes University Hospital
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2014-08
Primary Completion Date 2022-03-16
Completion Date 2022-03-16